Insider sale
NEURONETICS, INC.
$10.88M
2.93M shares
What this filing means
MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP plans to sell 2.93M shares of NEURONETICS, INC. valued at approximately $10.88M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/8/2025ACC: 0001950047-25-005570
10% Owner
Since Dec 2024
2.93M
Shares to sell
$10.88M
Approx. market value
2.93M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Merger/Acquisition
Cash
12/10/2024
2.93MTotal acquired2.93M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/10/2024 | Merger/Acquisition Cash | 2.93M | — |
| Total | 2.93M | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.93M
Market value
$10.88M
8/8/2025
Total
Units
2.93M
Value
$10.88M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/8/2025 | 2.93M | $10.88M | NASDAQ | Planned |
| Total | 2.93M | $10.88M | ||